Jalra-M 50 mg/1000 mg Tablet is primarily utilised to manage blood sugar levels in adults diagnosed with type 2 diabetes mellitus. This medication is a combination of two antidiabetic medicines and falls under the categories of dipeptidyl peptidase-4 (DPP-4) inhibitors and biguanides.
Alongside its principal use, this medicine can be prescribed when metformin on its own does not provide sufficient control of blood sugar levels. Furthermore, it may be recommended if you are already taking both metformin and vildagliptin as separate tablets. The ultimate aim is to prevent serious long-term complications associated with diabetes, such as kidney damage, blindness, and nerve problems.
It is essential to take this tablet as directed by your doctor, who will determine the appropriate dosage based on your health condition. Prior to starting this medicine, inform your doctor about any existing health issues or current medications. If you experience any side effects, promptly notify your doctor. For optimal results, continue taking this tablet for the duration prescribed by your doctor.